Log on / register
Feedback | Support | My details
Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats.
Astrand J, Harding AK, Aspenberg P, Tägil M
BMC Musculoskelet Disord 2006, 7:63
[Full text] [PubMed] [Related articles]


No citations for this article were found in PubMed Central.


You can also check ISI Web of Science for additional citations (subscription required)
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.